Smoking history: tumor biology and clinical pharmacokinetic implications in patients with lung cancer
- PMID: 16800960
Smoking history: tumor biology and clinical pharmacokinetic implications in patients with lung cancer
Comment on
-
Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21.Clin Lung Cancer. 2006 May;7(6):389-94. doi: 10.3816/clc.2006.n.022. Clin Lung Cancer. 2006. PMID: 16800964 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical